PORTUGAL IV HYDRATION THERAPY MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026 - 2033)

Portugal IV Hydration Therapy Market Size and Forecast – 2026 to 2033

The Portugal IV hydration therapy market is estimated to be valued at USD 62.8 Mn in 2026 and is expected to reach USD 92.0 Mn by 2033, exhibiting a compound annual growth rate (CAGR) of 6.5% from 2026 to 2033.

A growing public understanding and surge in the need for effective hydration methods contribute to the adoption of IV hydration therapy. The Direcao-Geral da Saude (DGS) recommends the daily consumption of 1.5-2.5 liters of water depending on age, gender, and physical activity levels.

Gaps in adherence to these guidelines are further increasing the need for IV hydration solutions. A 2023 peer-reviewed study conducted by researchers at Lusofona University found that institutionalized elderly individuals in Lisbon area did not meet recommended fluid intake levels, highlighting a significant hydration gap among a high-risk population group.

Key Takeaways of the Portugal IV Hydration Therapy Market

• Immunity booster segment is expected to lead the Portugal IV hydration therapy market, capturing 28.2% share in 2026.
• Medicated segment is estimated to represent 66.8% of the Portugal IV hydration therapy market share in 2026.
• Female segment is projected to dominate with 57.2% of the Portugal IV hydration therapy market share in 2026.

Market Overview

• The Portugal IV hydration therapy market is undergoing a transition from a clinical therapy segment to a hybrid segment consisting of medical and wellness therapy.
• Urban wellness trends and preventive medicine choices, particularly by individuals requiring energy-boosting therapy, recovery assistance, and cosmetic therapy including skin hydration and anti-aging therapy, are boosting the market growth.
• The Portugal IV hydration therapy market is a service-driven segment, mostly in private medical facilities; however, hospitals continue to lead in clinical therapy usage.
• Regulatory control is a significant factor affecting the Portugal IV hydration therapy market; medical supervision is a necessity in IV therapy, thus limiting commercialization and maintaining a controlled pace in the growth of the Portugal IV hydration therapy market.

Segmental Insights 

To learn more about this report, Download Free Sample

Why Does the Immunity Booster Segment Dominate the Portugal IV Hydration Therapy Market in 2026?

The immunity booster segment is projected to hold a market share of 28.2% in 2026, owing to strong focus among people on ways to boost the immune system, especially in the light of the recent health challenges such as the impact of COVID-19, recurring seasonal influenza outbreaks, and rising incidence of respiratory infections among the aging population in Portugal.

IV hydration therapy is an effective way for people to enhance their health as they can obtain vitamins such as Vitamin C, Zinc, and antioxidants quickly. Additionally, the prevalence of chronic conditions, coupled with higher infection rates during winter seasons in Portugal, is supporting the use of immunity boosters alongside conventional treatments.

For instance, in Portugal, influenza is known to have an annual pattern with cases occurring in winter, spanning the period from October to May. During the winter season of 2026, influenza cases were reported to have reached 1,265 cases in just one week. This is an indication of the rising cases of influenza in the winter season. Moreover, according to historical data, influenza cases are known to have reached tens of thousands on an annual basis, with an average of about 33,668 cases.

Why Does the Medicated Segment Dominate the Portugal IV Hydration Therapy Market in 2026?

The medicated segment is projected to hold a market share of 66.8% in 2026. This is largely because both consumers and healthcare professionals are seeking more than just hydration from these treatments. Medicated IV infusions incorporate pharmaceutical-grade active ingredients. These include vitamins B12 and B7, Ondansetron, and other powerful compounds. They are designed to address a range of health issues, including fatigue, hangovers, vitamin deficiencies, and nausea to name a few. The level of specificity helps to instill confidence in the product among consumers and is a key factor that makes medicated IV infusions a solution for health and wellness.

The presence of a well-organized healthcare system in Portugal, supported by universal healthcare coverage and low unmet medical needs (2.4%, below the OECD average), along with an increased level of acceptance of integrative medicine, also facilitates the accessibility of IV therapy with medicated medication. This is because patients who require specific relief or improvement tend to look for medicated IV therapy, as the infusion is provided as per the patient's requirements, thereby creating a greater level of perceived value.

For example, medication such as Ondansetron, which aids in relieving symptoms such as nausea and vomiting, is popular among patients who undergo rigorous treatments or who experience such symptoms, whereas vitamin B12 IV is popular among patients who experience energy depletion.

For instance, Medicated IV therapy has been commonly administered in clinical practice settings to deliver specific treatment interventions. To illustrate, Ondansetron is administered intravenously to prevent nausea and vomiting in patients undergoing chemotherapy and surgical procedures, which underlines the need to develop condition-specific medicated IV products. The administration of medicated IV therapy in the treatment of nausea and vomiting, as opposed to hydration IV therapy, further supports the choice of medicated IV therapy, thereby reiterating the dominance of medicated IV therapy.

The Female Segment Dominates the Portugal IV Hydration Therapy Market

The female segment is expected to hold the largest market share of 57.2% in 2026, reflecting women's heightened interest in health optimization and beauty enhancement treatments. Female consumers' adoption of IV hydration solutions, which are marketed for multiple benefits, is mainly influenced by a desire to align with preventive wellness trends and therapies focused on results, rather than by aesthetic considerations.

Female consumers show stronger engagement with wellness-oriented therapies that offer both immediate experiential benefits and clinically relevant outcomes, supporting adoption of solutions such as IV hydration therapy. For example, women are drawn to IV hydration drinks infused with vitamins such as Vitamin C and Glutathione. They believe these vitamins will improve their skin, slow down aging, and detoxify their bodies, aligning perfectly with their beauty goals.

For instance, In Portugal, the gender-based consumption patterns show that only 9.7% of women consume alcohol daily, as compared to 33.4% of males, indicating that the female consumers have a stronger propensity towards health and wellness. The behavior is likely to have a positive influence on the potential adoption rate of IV hydration therapy.

The Integration of Digital Access and Concierge Service Models

• Adoption of Digital Booking and Concierge Service Platforms – IV hydration therapy providers in Portugal, especially those in Lisbon and the Algarve, are embracing online booking systems, mobile scheduling, and concierge-level service. This evolution allows for on-demand IV treatments to be delivered in homes, hotels, and wellness centers, expanding availability for locals and visitors alike. The move toward digital service delivery is boosting customer convenience, streamlining operations, and increasing appointment utilization. It's also fueling the expansion of premium, experience-focused IV therapy options in the market.
• Standardization of Medically Supervised IV Therapy Protocols- In Portugal, the use of intravenous (IV) hydration therapy is steadily becoming more clinical. They're adopting protocols that involve physician supervision, standardized formulations, and controlled administration methods. This trend is especially noticeable in private clinics, which serve both locals and medical tourists. Consequently, the market is seeing a boost in treatment credibility, a decrease in clinical risk, and a clearer distinction between licensed providers and those operating informally. This shift supports the market's long-term viability and helps with premium positioning.

Market Players, Key Developments, and Competitive Intelligence

To learn more about this report, Download Free Sample

Key Developments

• In December 2025, Fresenius Kabi unveiled its new biosimilar products in Europe. The company also continued to broaden its IV drugs and infusion therapy offerings throughout the region.
• In June 2025, Droplet IV announced that it had received funding worth US$ 2 million. This money is earmarked for the commercial rollout of its automatic IV-line flushing device, which is slated to hit EU markets (including Portugal) and the U.S. by 2026.
• In May 2025, Otsuka Pharmaceutical, via its subsidiary Otsuka Pharmaceutical Factory, made a significant strategic decision. The two companies teamed up with ICU Medical, a strategic partnership designed to enhance the production and development of intravenous (IV) solutions.

Stringent Regulatory Environment Shaping Safe and Structured Market Growth

• Regulatory Framework and Compliance Landscape- The Portugal IV hydration therapy market operates within the framework of European Union regulations. These guidelines encompass medical devices, pharmaceuticals, and the practices involved in clinical settings. Infarmed is responsible for ensuring that IV formulations, infusion devices, and therapies are safe, of good quality, and effective. Compliance with European Union regulations, including the Medical Device Regulation and Good Manufacturing Practices, is essential, particularly for sterile intravenous (IV) formulations and infusion devices. While these regulations effectively safeguard patient well-being, they simultaneously present challenges for new and smaller market entrants.
• Evolving Policies and Market Implications- Evolving policies are influencing the market, regulatory agencies are closely monitoring IV hydration therapy within the wellness and non-clinical sectors, emphasizing the necessity of professional oversight and clinical justification for such treatments. Furthermore, the European Medicines Agency's guidance in Europe is advocating for increased regulation of IV therapy, encompassing off-label and lifestyle applications. Although this might initially slow the growth of IV hydration clinics, it ultimately benefits the long-term health of this industry.

Top Strategies Followed by Portugal IV Hydration Therapy Market Players

Uncover macros and micros vetted on 75+ parameters: Get instant access to report

Market Report Scope 

Portugal IV Hydration Therapy Market Dynamics

To learn more about this report, Download Free Sample

Portugal IV Hydration Therapy Market Driver - Rising Awareness of IV Hydration’s Benefits Among Consumers

Increased awareness among consumers regarding the health and wellness benefits of IV hydration therapy is proving to be a significant factor in the growth of the IV hydration therapy market in Portugal. Increasing awareness of IV hydration therapy benefits among general public is expected to sustain demand growth, particularly across wellness-driven and lifestyle-focused applications. This is especially true among the population of Portugal and the country’s working professionals who are looking to quickly recover from the effects of a hectic lifestyle and the consequent dehydration and fatigue caused by it.

For instance, Drip IV Portugal, among other providers, offers IV hydration therapy through a mobile service, which means they take the service directly to the patient, whether they are in Lisbon, Algarve, or other areas in Portugal. This service can be accessed in a convenient location such as a patient’s residence, hotel, or even a place of work, and they use a specially formulated solution to improve levels of hydration, boost energy, and even improve immunity.

Portugal IV Hydration Therapy Market Opportunity - Growth of Medical Tourism and Wellness Tourism in Portugal

The Portugal IV hydration therapy market is expected to benefit greatly from the increasing medical tourism and wellness tourism markets in Portugal. Portugal has emerged as a popular destination for medical tourists and wellness seekers because of its highly developed medical infrastructure, low treatment costs, and high standards of medical care.

For instance, the improved attractiveness of Portugal as a health and wellness destination can be understood in the context of the country’s strong tourism industry, which received about 30 Mn tourists in 2024, while close to USD 31 Bn (€27 Bn) in tourism revenues was generated, as published by Turismo de Portugal.

Additionally, the quality and access of the Portuguese healthcare system are at a high level, with the presence of modern hospital facilities and cost-effective treatment methods. Portugal ranks 23rd in the world on the 2024 World Index of Healthcare Innovation. This is a result of the highly developed health care system in Portugal.

Furthermore, the growing awareness among medical tourists regarding preventive medical care and wellness has resulted in a high demand for innovative medical treatments, thereby providing an added advantage to the Portugal IV hydration therapy market. The pleasant climate, beautiful locations, and highly developed hospitality sector in Portugal have made it an attractive destination for tourists, thus providing an added advantage to the Portugal IV hydration therapy market.

Analyst Opinion (Expert Opinion)

• The Portugal IV therapy market is expected to see a shift towards a premium and a tourism-driven model, with service providers increasingly looking to leverage the high-end hospitality infrastructure in Lisbon and Algarve to boost the average revenue per user.
• The Portugal IV therapy market is expected to see a formalization of the sector with regulatory intensity increasing on non-clinical IV therapy administration, making it a challenge for new entrants and favoring established private clinics.
• Providers are expected to increasingly look towards asset-light and concierge-based service delivery models to improve the reach of IV therapy services on demand and across various hospitality and residential infrastructure.
• The competition in the Portugal IV therapy market is expected to see a shift towards a differentiated model with providers increasingly looking towards customized IV formulations and treatment plans to improve the scope of use cases such as fatigue recovery, immunity boosters, and travel-related dehydration.

Market Segmentation

• Service Type Insights (Revenue, USD Mn, 2021 - 2033)
  • Immunity Booster
  • Hangover Cure
  • Energy Booster
  • Skin Care
  • Vitamin
    • Vitamin C
    • Glutathione
    • Vitamin B7
    • NAD (Nicotinamide Adenine Dinucleotide)
    • Vitamin B12
    • Ondansetron
    • Others (Magnesium Chloride, Zinc Chloride, etc.)
  • Others (Weight Loss, among others)
• Component Type Insights (Revenue, USD Mn, 2021 - 2033)
  • Medicated
  • Non-Medicated
• Gender Insights (Revenue, USD Mn, 2021 - 2033)
  • Female
  • Male
• Age Group Insights (Revenue, USD Mn, 2021 - 2033)
  • Children
  • Adult
  • Geriatric
• Economy Insights (Revenue, USD Mn, 2021 - 2033)
  • Business Class
  • Working Class
• Income Group Insights (Revenue, USD Mn, 2021 - 2033)
  • Low Income
  • Middle Income
  • High Income
• Activity Insights (Revenue, USD Mn, 2021 - 2033)
  • Emergency Healthcare
  • Routine Healthcare
• Key Players Insights
  • Baxter International Inc.
  • Otsuka Pharmaceutical Co., Ltd.
  • Braun Medical Inc.
  • JW Life Science Corporation
  • Amanta Healthcare
  • Fresenius Kabi
  • Terumo Corporation
  • Grifols
  • Pfizer
  • Abbott Laboratories
  • ICU Medical Inc.
  • Becton Dickinson and Company
  • Nipro Corporation
  • Oculus Innovative Sciences
  • Terra Universal

Sources

Primary Research Interviews

Industry Stakeholders

• Hospital Administrators
• Clinical Pharmacists
• Infusion Therapy Specialists
• Medical Device Engineers
• Healthcare Policy Experts
• Private Clinic Owners

End Users List

• Patients with Chronic Conditions
• Elderly Population
• Wellness and Fitness Consumers
• Medical Tourists
• Corporate Wellness Participants
• Post-Surgery Recovery Patients

Government and International Databases

• Infarmed
• European Medicines Agency
• World Health Organization
• OECD
• Eurostat
• Direcao-Geral da Saude

Trade Publications

• MedTech Europe
• PharmaTimes
• European Pharmaceutical Review
• Healthcare IT News
• Medical Device Network
• Pharmaceutical Technology

Academic Journals

• The Lancet
• BMJ
• Journal of Clinical Medicine
• International Journal of Clinical Practice
• European Journal of Hospital Pharmacy
• Journal of Infusion Nursing

Reputable Newspapers

• Financial Times
• The Guardian
• The New York Times
• El Pais
• Publico
• Expresso

Industry Associations

• European Federation of Pharmaceutical Industries and Associations
• MedTech Europe
• European Society of Clinical Pharmacy
• International Society of Aesthetic Plastic Surgery
• European Society for Clinical Nutrition and Metabolism
• Portuguese Pharmaceutical Society

Public Domain Resources

• Google Scholar
• ClinicalTrials.gov
• EU Open Data Portal
• World Bank Open Data
• OECD Data

Proprietary Elements

• CMI Data Analytics Tool: Proprietary analytics tool to analyze real-time market trends, consumer behavior, and technology adoption in market
• Proprietary CMI Existing Repository of Information for Last 10 Years